|
|
Effect of Clopidogrel combined with Aspirin in the treatment of acute myocardial infarction |
FANG Yang JIN Lei |
Department of Cardiology, Benxi Central Hospital, Liaoning Province, Benxi 117000, China |
|
|
Abstract Objective To investigate the effect of Clopidogrel combined with Aspirin in the treatment of acute myocardial infarction.Methods A total of 86 patients with acute myocardial infarction admitted to Benxi Central Hospital from December 1, 2018 to January 15, 2020 were selected as the research objects.According to the odd and even number grouping method, they were divided into the observation group and the control group, with 43 cases in each group.The observation group was treated with Clopidogrel combined with Aspirin, while the control group was treated with Aspirin.The therapeutic effect, cardiac function changes before and after treatment (left ventricular ejection fraction [LVEF], left ventricular end-diastolic diameter [LVEDD], 6 min walking distance [6MWD]), cardiovascular events and the total incidence of adverse reactions in the two groups were compared.Results The total effective rate in observation group(97.67%) was higher than that in control group (79.07%), and the difference was statistically significant (P<0.05).After treatment, LVEF and 6MWD in the observation group were higher than those in the control group, LVEDD was lower than that in the control group, and the differences were statistically significant (P<0.05).The total incidence of cardiovascular events in the observation group (4.65%) was lower than that in the control group (18.60%), the total incidence of adverse reactions in the observation group (4.65%) was lower than that in the control group (18.60%), and the differences were statistically significant (P<0.05).Conclusion The combination of Clopidogrel and Aspirin in the treatment of acute myocardial infarction can significantly improve heart function and have a low incidence of cardiovascular events.It is worthy of clinical promotion and application.
|
|
|
|
|
[1] |
孙黎博,李西红.氯吡格雷联合阿司匹林急诊治疗对急性心肌梗死患者血清IL-6、IL-10 水平的影响[J].贵州医药,2020,44(3):371-373.
|
[2] |
马飞,李伟峰,杨仁强,等.氯吡格雷联合阿司匹林肠溶片对急性心肌梗死患者凝血功能的影响[J].血栓与止血学,2020,26(1):55-56.
|
[3] |
赵博,彭建军,任利辉.双倍剂量氯吡格雷治疗CYP2C19中间代谢型老年急性心肌梗死患者的效果[J].中华老年多器官疾病杂志,2020,19(5):355-359.
|
[4] |
中华医学会心血管病学分会,中华心血管病杂志编辑委员会.急性ST 段抬高型心肌梗死诊断和治疗指南(2019)[J].中华心血管病杂志,2019,47(10):766-783.
|
[5] |
刘亮,李雪梅,韩建伦.胺碘酮联合氯吡格雷治疗心肌梗死的疗效及对患者血清炎症因子及凝血功能的影响[J].海南医学,2020,31(8):976-979.
|
[6] |
]辛建军,王志婧.氯吡格雷联合替格瑞洛溶栓治疗急性ST 段抬高型心肌梗死的临床疗效观察[J].贵州医药,2020,44(5):769-771.
|
[7] |
常国栋,陈英伟.替格瑞洛在氯吡格雷抵抗急性心肌梗死患者PCI 术后抗血小板治疗中的应用效果[J].中国循证心血管医学杂志,2018,10(4):466-468.
|
[8] |
刘寅,高静.中国急性心肌梗死救治新进展及挑战[J].天津医药,2017,45(11):1124-1129.
|
[9] |
唐娟.替格瑞洛联合阿司匹林对急性心肌梗死PCI 患者术后血小板参数及心电图的影响[J].血栓与止血学,2018,24(1):42-44.
|
[10] |
董艳丽,董淑娟.替格瑞洛片联合阿司匹林片用于经皮冠状动脉介入术的急性ST 段抬高型心肌梗死患者的临床研究[J].中国临床药理学杂志,2019,35(7):16-18.
|
[11] |
金朝霞,万里鹏,覃艳琼.氯吡格雷联合阿司匹林治疗急性心肌梗死的临床效果[J].心血管康复医学杂志,2018,27(5):554-557.
|
[12] |
郭仕俊,苏令,章福彬,等.氯吡格雷联合肠溶性阿司匹林在急性心肌梗死治疗中的应用[J].蚌埠医学院学报,2017,42(4):458-461.
|
[13] |
刘剑刚,张蕾,张庆翔,等.急性心肌梗死大鼠联合应用阿司匹林和氯吡格雷致胃黏膜损伤及微循环改变[J].微循环学杂志,2017,27(2):1-7.
|
[14] |
周伟伟,谷惠敏,吕晓蕾,等.氯吡格雷联合阿司匹林治疗老年急性心肌梗死的疗效分析[J].河北医药,2018,40(14):2186-2188,2192.
|
[15] |
任军,高建平.氯吡格雷联合阿司匹林治疗心肌梗死的效果观察[J].山西医药杂志,2020,49(9):1145-1147.
|
[16] |
冼文川,林力峰,林智君.拜阿司匹林联合氯吡格雷治疗急性轻型脑梗死的临床疗效及不良反应分析[J].中国医药科学,2020,10(1):91-93.
|
|
|
|